(PDF) 414 Pharmacokinetic Basis for Antenatal Dosing of

414 Pharmacokinetic Basis for Antenatal Dosing of Phenobarbital for the Prevention of Neonatal Intracere BRRL Hemorrhage

Pediatric Research - United States

doi 10.1203/00006450-198504000-00444

Full Text

Abstract

Available in full text

Categories

Date

April 1, 1985

Authors

Seetha Shankaran

Ralph Kauffirtan

Publisher

Springer Science and Business Media LLC

Related search

Effectiveness and Safety of Prenatal Phenobarbital for the Prevention of Neonatal Jaundice

Pediatric Research

English

Clinical Aspects of Antenatal Glucocorticoid Treatment for Prevention of Neonatal Respiratory Distress Syndrome

Journal of Perinatal Medicine

English

Ribozyme Pharmacokinetic Screening for Predicting Pharmacodynamic Dosing Regimens

Current Issues in Molecular Biology

Molecular Biology

English

Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing

Pharmacotherapy

English

Therapeutic Drug Monitoring for the Individualization of Docetaxel Dosing: A Randomized Pharmacokinetic Study

Clinical Cancer Research

Cancer Research

English

Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

The Effect of Reporting Methods for Dosing Times on the Estimation of Pharmacokinetic Parameters of Escitalopram

Journal of Clinical Pharmacology

English

Adverse Neurodevelopmental Outcomes After Exposure to Phenobarbital and Levetiracetam for the Treatment of Neonatal Seizures

Journal of Perinatology

English

Pharmacokinetic Interactions and Dosing Rationale for Antiepileptic Drugs in Adults and Children

British Journal of Clinical Pharmacology

English